Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals, Inc. | -0.41% | 570.06 | 2.7% | $662.15m | |
| AMGN | Amgen, Inc. | -0.64% | 227.50 | 1.3% | $583.41m | |
| ILMN | Illumina, Inc. | 1.00% | 321.03 | 3.5% | $561.02m | |
| GILD | Gilead Sciences, Inc. | -0.77% | 59.75 | 1.0% | $497.52m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.49% | 210.34 | 1.9% | $485.95m | |
| MRNA | Moderna, Inc. | 2.84% | 70.31 | 0.0% | $485.11m | |
| ARRY | Array BioPharma Inc. | -0.79% | 39.03 | 14.2% | $474.59m | |
| IMMU | Immunomedics, Inc. | 0.05% | 87.87 | 11.0% | $373.48m | |
| NVAX | Novavax, Inc. | 1.18% | 92.24 | 96.5% | $306.38m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.63% | 118.93 | 2.0% | $282.17m | |
| BIIB | Biogen, Inc. | -1.19% | 265.71 | 1.6% | $261.45m | |
| EXAS | EXACT Sciences Corp. | 1.33% | 100.94 | 20.7% | $222.48m | |
| BNTX | BioNTech SE | -1.43% | 86.47 | 0.0% | $211.61m | |
| SRNE | Sorrento Therapeutics, Inc. | 0.76% | 7.91 | 1.4% | $182.71m | |
| SGEN | Seagen Inc. | -0.16% | 197.39 | 6.0% | $162.10m |
Company Profile
Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing Antibody Radiation-Conjugates, which combine the targeting ability of antibodies with the cell killing ability of radiation. The firm provides its service through Iomab-B, which is studied in the ongoing pivotal Phase 3 Study of Iomab-B in Elderly Relapsed or Refractory Acute Myeloid Leukemia (SIERRA) trial for BMT conditioning. The company was founded in 2002 and is headquartered in New York, NY.